FDA 483 - Puerto Rico Fertility and Reproductive Center PSC - March 18, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Puerto Rico Fertility and Reproductive Center PSC, a human tissue establishment in Bayamon, PR, was cited for significant deficiencies in its oocyte donor screening and testing processes. The inspection revealed that donors were not adequately screened for communicable disease risk factors, including ZIKV, and donor eligibility determinations were made before required communicable disease testing was completed or with improperly timed specimens. These issues indicate a serious lack of control over donor suitability, potentially compromising recipient safety.
- Inspection Date
- March 18, 2022
- Product Type
- Biologics
ID · 09636f94-f9a4-4599-9b0e-f07f4f8cff39